Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,534,500
-$5,649,000 QoQ
Shares Held
1,050,000
0.0% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
3.76%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 20265AM Venture Management, LLC holds $360,212,474 across 20 Biotechnology names. EYPT ranks #11 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ERAS |
Erasca, Inc.
|
3,485,971 | $56,403,010 | |
| 2 | TRDA |
Entrada Therapeutics, Inc.
|
4,056,379 | $51,191,502 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
1,029,298 | $39,422,113 | |
| 4 | CAMP |
Camp4 Therapeutics Corp
|
5,869,091 | $25,882,691 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
580,945 | $23,075,135 | |
| 6 | PHVS |
Pharvaris N.V.
|
797,600 | $22,532,200 | |
| 7 | MPLT |
MapLight Therapeutics, Inc.
|
950,011 | $19,313,723 | |
| 8 | TECX |
Tectonic Therapeutic, Inc.
|
606,660 | $18,751,860 |
All Filings in EYPT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,534,500 | 1,050,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,183,500 | 1,050,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,952,000 | 1,050,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,880,500 | 1,050,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,691,000 | 1,050,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,822,500 | 1,050,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,389,500 | 1,050,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $435,000 | 50,000 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||